Mortality, causes of death, and health status among methamphetamine users

Journal of Addictive Diseases

Volumn 34, Issue 1, 2015, Pages 88-100

  Herbeck, Diane M ^a   Brecht, Mary Lynn ^a   Lovinger, Katherine ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Methamphetamine; morbidity; mortality; substance use disorder treatment

Indexed keywords

METHAMPHETAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME NURSING; ADULT; ARTICLE; CAUSE OF DEATH; DRUG USE; FEMALE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POPULATION; PUBLIC HEALTH; SUBSTANCE USE; AMPHETAMINE-RELATED DISORDERS; DRUG DEPENDENCE TREATMENT; INTERVIEW; LONGITUDINAL STUDY; MENTAL DISORDERS; MIDDLE AGED; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGY; RISK FACTOR; UNITED STATES;

ADULT; AMPHETAMINE-RELATED DISORDERS; CAUSE OF DEATH; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEALTH STATUS; HUMANS; INTERVIEWS AS TOPIC; LONGITUDINAL STUDIES; MALE; MENTAL DISORDERS; METHAMPHETAMINE; MIDDLE AGED; RISK FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; UNITED STATES;

EID: 84928612343     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2014.975610     Document Type: Article

References (42)

1. Darke S., Kaye S., McKetin R., Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 2008; 27: 253-62.
2. Kaye S., Darke S., Duflou J., McKetin R. Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology, and major organ pathology. Addiction 2008; 103: 1353-60.
3. Lineberry TW., Bostwick JM. Methamphetamine abuse: a perfect storm of complications. Mayo Clin Proc 2006; 81: 77-84.
4. Ribeiro M., Dunn J., Sesso R., Lima MS., Laranjeira R. Crack cocaine: a five-year follow-up study of treated patients. Eur Addict Res 2007; 13: 11-9.
5. Borders TF., Booth BM., Falck RS., Leukefeld C., Wang J., Carlson RG. Longitudinal changes in drug use severity and physical health-related quality of life among untreated stimulant users. Addict Behav 2009; 34: 959-64.
6. Callaghan RC., Cunningham JK., Verdichevski M., Sykes J., Jaffer SR., Kish SJ. All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study. Drug Alcohol Depend 2012; 125: 290-4.
7. Liang LJ., Huang D., Brecht ML., Hser YI. Differences in mortality among heroin, cocaine, and methamphetamine users: a hierarchical bayesian approach. J Drug Issues 2010; 40: 121-40.
8. Kaye S., McKetin R., Duflou J., Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007; 102: 1204-11.
9. Fridell M., Hesse M. Psychiatric severity and mortality in substance abusers: a 15-year follow-up of drug users. Addict Behav 2006; 31: 559-65.
10. Kalechstein AD., Newton TF., Longshore D., Anglin MD., van Gorp WG., Gawin FH. Psychiatric comorbidity of methamphetamine dependence in a forensic sample. J Neuropsychiatry Clin Neurosci 2000; 12: 480-4.
11. Chen CY., Wu PN., Su LW., Chou YJ., Lin KM. Three-year mortality and predictors after release: a longitudinal study of the first-time drug offenders in Taiwan. Addiction 2010; 105: 920-7.
12. Kittirattanapaiboon P., Mahatnirunkul S., Booncharoen H., Thummawomg P., Dumrongchai U., Chutha W. Long-term outcomes in methamphetamine psychosis patients after first hospitalisation. Drug Alcohol Rev 2010; 29: 456-61.
13. Karch SB., Stephens BG., Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci 1999; 44: 359-68.
14. Stenbacka M., Leifman A., Romelsjö A. Mortality and cause of death among 1705 illicit drug users: a 37 year follow up. Drug Alcohol Rev 2010; 29: 21-7.
15. Degenhardt L., Roxburgh A., Black E, et al. The epidemiology of methamphetamine use and harm in Australia. Drug Alcohol Rev 2008; 27: 243-52.
16. Gossop M., Stewart D., Treacy S., Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction 2002; 97: 39-47.
17. Muhuri PK., Gfroerer JC. Mortality associated with illegal drug use among adults in the United States. Am J Drug Alcohol Ab 2011; 37: 155-64.
18. Finney J., Moos R., Timko C. The course of treated and untreated substance use disorders: remission and resolution, relapse, and mortality. In: McCrady B., Epstein E., eds. Addictions: A comprehensive guidebook. New York: Oxford; 1999: 30-49.
19. Brecht ML., OBrien A., von Mayrhauser C., Anglin MD. Methamphetamine use behaviors and gender differences. Addict Behav 2004; 29: 89-106.
20. Scott CK. A replicable model for achieving over 90% follow-up rates in longitudinal studies of substance abusers. Drug Alcohol Depend 2004; 74: 21-36.
21. McGlothlin WH., Anglin MD., Wilson BD. A follow-up of admissions to the California Civil Addict Program. Am J Drug Alcohol Ab 1977; 4: 179-99.
22. Murphy DA., Hser YI., Huang D., Brecht ML., Herbeck DM. Self-report of longitudinal substance use: a comparison of the UCLA Natural History Interview and the Addiction Severity Index. J Drug Issues 2010; 40: 495-516.
23. World Health Organization. Manual of the international statistical classification of diseases, injuries, and causes of death, based on the recommendations of the ninth revision conference, 1975. Geneva: World Health Organization; 1977.
24. Beck AT., Steer RA. Manual for the revised Beck Depression Inventory. San Antonio, TX: The Psychological Corporation; 1987.
25. Arias E. National vital statistics report 2006 U.S. life tables, 58 (21). Hyattsville, MD: National Center for Health Statistics; 2010.
26. Szklo M., Nieto FJ. Epidemiology: beyond the basics (2nd ed.). Sudbury, MA: Jones and Bartlett; 2007.
27. Murphy S., Xu J., Kochanek KD. National vital statistics reports. National Center for Health Statistics. Vital Health Stats 6; 2013.
28. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 1990; 2 (131): 373-5.
29. Schiller JS., Lucas JW., Ward BW., Peregoy JA. Summary health statistics for U.S. adults: National Health Interview Survey, 2010. 10(252). Hyattsville, MD: National Center for Health Statistics, Vital Health Statistics; 2012.
30. Hser YI., Kagihara J., Huang D., Evans E., Messina N. Mortality among substance-using mothers in California: a 10-year prospective study. Addiction 2012; 107: 215-22.
31. Kuo CJ., Liao YT., Chen WJ., Tsai SY., Lin SK., Chen CC. Causes of death of patients with methamphetamine dependence: a record-linkage study. Drug Alcohol Rev 2011; 30: 621-8.
32. Yang JC., Huang D., Hser Y. Long-term morbidity and mortality among a sample of cocaine-dependent black and white veterans. J Urban Health 2006; 83: 926-40.
33. Copeland AL., Sorensen JL. Differences between methamphetamine users and cocaine users in treatment. Drug Alcohol Depend 2001; 62: 91-5.
34. Butler R., Wheeler A., Sheridan J. Physical and psychological harms and health consequences of methamphetamine use amongst a group of New Zealand users. Int J Ment Health Addict 2010; 8: 432-43.
35. McKetin R., Kelly E., McLaren J., Proudfoot H. Impaired physical health among methamphetamine users in comparison with the general population: the role of methamphetamine dependence and opioid use. Drug Alcohol Rev 2008; 27: 482-9.
36. Bohnert AS., Ilgen MA., Ignacio RV., McCarthy JF., Valenstein M., Blow FC. Risk of death from accidental overdose associated with psychiatric and substance use disorders. Am J Psychiat 2012; 169: 64-70.
37. Muazzam S., Swahn MH., Alamgir H., Nasrullah M. Differences in poisoning mortality in the United States, 2003-2007: epidemiology of poisoning deaths classified as unintentional, suicide, or homicide. West J Emerg Med 2012; 13: 230-8.
38. Fairbairn N., Wood E., Stoltz JA., Li K., Montaner J., Kerr T. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver. Public Health 2008; 122: 70-8.
39. Marshall BDL, Grafstein E, Buxton JA, Qi J, Wood E, Shoveller JA, & Kerr T. Frequent methamphetamine injection predicts emergency department utilization among street-involved youth. Public Health 2012; 126: 47-53.
40. Herbeck DM., Brecht ML., Pham AZ. Racial/ethnic differences in health status and morbidity among adults who use methamphetamine. Psychol Health Med 2013; 18: 262-74.
41. Corsi KF., Booth RE. HIV sex risk behaviors among heterosexual methamphetamine users: literature review from 2000 to present. Curr Drug Abuse Rev 2008; 1: 292-6.
42. Ho EL., Josephson SA., Lee HS., Smith WS. Cerebrovascular complications of methamphetamine abuse. Neurocrit Care 2009; 10: 295-305.